ipilimumab,nivolumab
bms
['ts,perio,1', 'nivo', 'surpass', 'ipi/', 'ts,perio,i', 'esophageal']
the great dr al-batran discuses vestige trial results (adj flot vs ipi/nivo in pn+/r1 gastro-oesophageal adeno) at #wcgic2023. most important learning point from this negative trial: postop flot should be given to pts with pn+/r1 in resection specimen &gt;&gt; much better dfs. 
Academic GI Cancer Centre in the City of London. Delivering evidence-based treatments and clinical trials to patients. Informing and education patients and HCPs